Ovarian Reserve Assessment for Infertility Investigation

Overview

Journal ISRN Obstet Gynecol

Publisher Hindawi

Specialty Gynecology & Obstetrics

Date 2012 Apr 5

PMID 22474591

Citations 18

Authors

Bruno Ramalho de Carvalho

David Barreira Gomes Sobrinho

Andrea Duarte Damasceno Vieira

Manoela Porto Silva Resende

Antonio Cesar Paes Barbosa

Adelino Amaral Silva

Hitomi Miura Nakagava

Affiliations

Soon will be listed here.

Abstract

The current trends to postpone motherhood and the increase in demand for assistance in reproductive medicine highlight the need for seeking guidelines for the establishment of individualized treatment protocols. Currently available ovarian reserve tests do not provide sufficient evidence to be solely considered ideal, but they may occupy important place in initial counseling, predicting unsatisfactory results that could be improved by individualized induction schemes and reducing excessive psychological and financial burdens, and adverse effects. In this paper, we revise the role of hormonal basal and dynamic tests, as well as ultrasonographic markers, as ovarian reserve markers, in order to provide embasement for propaedeutic strategies and their interpretation in order to have reproductive success.

Citing Articles

Should we routinely assess ovarian reserve in girls and young women with autoimmune thyroid disease?.

Wedrychowicz A, Wojtys J, Janus D, Furtak A, Stelmach M, Starzyk J Heliyon. 2024; 10(22):e40156.

PMID: 39634384 PMC: 11615472. DOI: 10.1016/j.heliyon.2024.e40156.

Correlation of Follicle-stimulating Hormone, Anti-Mullerian Hormone, and Antral Follicle Count with Age in Ovarian Reserve Testing.

Das S, Bhattacharya N, Mahata R, Ghosh S, Bhar A, Srivastava P Int J Appl Basic Med Res. 2024; 14(3):162-168.

PMID: 39310079 PMC: 11412561. DOI: 10.4103/ijabmr.ijabmr_81_24.

The Relationship Between Serum Anti-Müllerian Hormone and Basal Antral Follicle Count in Infertile Women Under 35 Years: An Assessment of Ovarian Reserve.

Islam U, Begum A, Rahman F, Haq M, Kumar S, Chowdhury K Cureus. 2023; 15(12):e50181.

PMID: 38077683 PMC: 10706210. DOI: 10.7759/cureus.50181.

Therapeutic Effect of Melatonin in Premature Ovarian Insufficiency: Hippo Pathway Is Involved.

Qi M, Sun T, Yang L, He J, Guo Y, Wang H Oxid Med Cell Longev. 2022; 2022:3425877.

PMID: 36017238 PMC: 9398856. DOI: 10.1155/2022/3425877.

Tanshinone IIA enhances the ovarian reserve and attenuates ovarian oxidative stress in aged mice.

Bai L, He G, Gao C, Yang H, Li M, Huang Y Vet Med Sci. 2022; 8(4):1617-1625.

PMID: 35451235 PMC: 9297741. DOI: 10.1002/vms3.811.

References

Kwee J, Elting M, Schats R, Bezemer P, Lambalk C, Schoemaker J . Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study. Hum Reprod. 2003; 18(7):1422-7. DOI: 10.1093/humrep/deg205. View

Frattarelli J, Bergh P, Drews M, Sharara F, Scott R . Evaluation of basal estradiol levels in assisted reproductive technology cycles. Fertil Steril. 2000; 74(3):518-24. DOI: 10.1016/s0015-0282(00)00693-2. View

Silberstein T, MacLaughlin D, Shai I, Trimarchi J, Lambert-Messerlian G, Seifer D . Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod. 2005; 21(1):159-63. DOI: 10.1093/humrep/dei270. View

Scheffer G, Broekmans F, Bancsi L, Habbema J, Looman C, Te Velde E . Quantitative transvaginal two- and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts. Ultrasound Obstet Gynecol. 2002; 20(3):270-5. DOI: 10.1046/j.1469-0705.2002.00787.x. View

Arabzadeh S, Hossein G, Hossein Rashidi B, Hosseini M, Zeraati H . Comparing serum basal and follicular fluid levels of anti-Müllerian hormone as a predictor of in vitro fertilization outcomes in patients with and without polycystic ovary syndrome. Ann Saudi Med. 2010; 30(6):442-7. PMC: 2994159. DOI: 10.4103/0256-4947.71063. View

de Vet A, Laven J, de Jong F, Themmen A, Fauser B . Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002; 77(2):357-62. DOI: 10.1016/s0015-0282(01)02993-4. View

Ficicioglu C, Kutlu T, Baglam E, Bakacak Z . Early follicular antimüllerian hormone as an indicator of ovarian reserve. Fertil Steril. 2006; 85(3):592-6. DOI: 10.1016/j.fertnstert.2005.09.019. View

McIlveen M, Skull J, Ledger W . Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population. Hum Reprod. 2006; 22(3):778-85. DOI: 10.1093/humrep/del435. View

Lee T, Liu C, Huang C, Hsieh K, Lin P, Lee M . Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles. Reprod Biol Endocrinol. 2009; 7:100. PMC: 2754482. DOI: 10.1186/1477-7827-7-100. View

10.

Fadini R, Comi R, Mignini Renzini M, Coticchio G, Crippa M, De Ponti E . Anti-mullerian hormone as a predictive marker for the selection of women for oocyte in vitro maturation treatment. J Assist Reprod Genet. 2011; 28(6):501-8. PMC: 3158257. DOI: 10.1007/s10815-011-9589-6. View

11.

Al-Azemi M, Killick S, Duffy S, Pye C, Refaat B, Hill N . Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction. Hum Reprod. 2010; 26(2):414-22. DOI: 10.1093/humrep/deq339. View

12.

Klein N, Illingworth P, Groome N, McNeilly A, Battaglia D, Soules M . Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab. 1996; 81(7):2742-5. DOI: 10.1210/jcem.81.7.8675606. View

13.

La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio A . Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2009; 16(2):113-30. DOI: 10.1093/humupd/dmp036. View

14.

Verhagen T, Hendriks D, Bancsi L, Mol B, Broekmans F . The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis. Hum Reprod Update. 2008; 14(2):95-100. DOI: 10.1093/humupd/dmn001. View

15.

Penarrubia J, Peralta S, Fabregues F, Carmona F, Casamitjana R, Balasch J . Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated with gonadotropin after pituitary suppression. Fertil Steril. 2010; 94(7):2590-5. DOI: 10.1016/j.fertnstert.2010.03.009. View

16.

de Carvalho B, Rosa-e-Silva A, Rosa-E-Silva J, dos Reis R, Ferriani R, Silva de Sa M . Anti-müllerian hormone is the best predictor of poor response in ICSI cycles of patients with endometriosis. Clin Exp Obstet Gynecol. 2011; 38(2):119-22. View

17.

Irez T, Ocal P, Guralp O, Cetin M, Aydogan B, Sahmay S . Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes. Arch Gynecol Obstet. 2011; 284(5):1295-301. DOI: 10.1007/s00404-011-1979-6. View

18.

Tinkanen H, Blauer M, Laippala P, Tuohimaa P, Kujansuu E . Correlation between serum inhibin B and other indicators of the ovarian function. Eur J Obstet Gynecol Reprod Biol. 2001; 94(1):109-13. DOI: 10.1016/s0301-2115(00)00319-5. View

19.

Te Velde E, Pearson P . The variability of female reproductive ageing. Hum Reprod Update. 2002; 8(2):141-54. DOI: 10.1093/humupd/8.2.141. View

20.

van Disseldorp J, Faddy M, Themmen A, de Jong F, Peeters P, van der Schouw Y . Relationship of serum antimüllerian hormone concentration to age at menopause. J Clin Endocrinol Metab. 2008; 93(6):2129-34. DOI: 10.1210/jc.2007-2093. View